Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Mesenchymal Stem Cells Market: By Source, By Applications, By End User, and Geography
Mesenchymal Stem Cells Market: By Source, By Applications, By End User, and Geography
Mesenchymal Stem Cells Market size was valued at US$ 2.70 billion in 2022 and is poised to grow at a CAGR of 12.6% from 2023-2029. Owing to increase in the prevalence of chronic diseases, degenerative, inflammatory, and autoimmune diseases. Scientific advancements and rising number of biotechnological companies across the globe are expected to propel the growth of the market. Additionally, enhancing application of mesenchymal stem cells for the treatment of chronic diseases, bone and cartilage diseases, and autoimmune diseases, the advantages of mesenchymal stem cells such as ease of isolation, high potential of regeneration and immunoregulatory nature and increasing demand for advanced healthcare facilities are expected to enhance the sale of mesenchymal stem cells market.
Study Period
2024-2030Base Year
2023CAGR
12.6%Largest Market
Asia-PacificFastest Growing Market
North-America
However, it is expected that maintaining a similar level of quality and functionality in MSCs across batches may hinder market growth. For research and clinical applications, the reliability and repeatability of data is required to be maintained by standard and quality control processes. Furthermore, the main challenge to the market's growth will be expected to be the high expense of care and the dearth of therapeutic improvements related to the in vitro advantages of stem cells.
North America accounted for larger revenue share in global mesenchymal stem cells market with significant CAGR owing to increasing number of research activities and advancements in technologies, availability of skilled personnel and advanced research facilities and presence of leading market players in the region are expected to increase the growth of the market over the forecasted years. Asia Pacific region is expected to grow at a significant growth rate over the forecast years owing to the enhanced healthcare infrastructure, and presence of large patient pool.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2022 |
US$ 2.70 billion |
|
Market CAGR |
12.6% |
|
By Source |
|
|
By Applications |
|
|
By End user |
|
Download Free Sample Report
The key segments covered in the mesenchymal stem cells market are: by source, applications, end-user and geography
The mesenchymal stem cells market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The mesenchymal stem cells market key players are: Cell Applications, Inc. (USA), Celprogen, Inc. (USA), Cyagen US Inc. (USA), Genlantis, Inc. (USA), Lonza Group (Switzerland)
| 1.Executive Summary |
| 2.Global Mesenchymal Stem Cells Market Introduction |
| 2.1.Global Mesenchymal Stem Cells Market - Taxonomy |
| 2.2.Global Mesenchymal Stem Cells Market - Definitions |
| 2.2.1.Source |
| 2.2.2.Applications |
| 2.2.3.End user |
| 2.2.4.Region |
| 3.Global Mesenchymal Stem Cells Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Mesenchymal Stem Cells Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Mesenchymal Stem Cells Market By Source, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Bone Marrow |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Umbilical Cord Blood |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Peripheral Blood |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Lung Tissue |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Synovial Tissues |
| 5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Amniotic Fluids |
| 5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Adipose Tissues |
| 5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 6.Global Mesenchymal Stem Cells Market By Applications, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Injuries |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Drug Discovery |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cardiovascular Infraction |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Mesenchymal Stem Cells Market By End user, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Clinical research organizations |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Biotechnological companies, |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Medical research institutes, |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Hospitals |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Mesenchymal Stem Cells Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Bone Marrow |
| 9.1.2.Umbilical Cord Blood |
| 9.1.3.Peripheral Blood |
| 9.1.4.Lung Tissue |
| 9.1.5.Synovial Tissues |
| 9.1.6.Amniotic Fluids |
| 9.1.7.Adipose Tissues |
| 9.2. Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Injuries |
| 9.2.2.Drug Discovery |
| 9.2.3.Cardiovascular Infraction |
| 9.2.4.Others |
| 9.3. End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Clinical research organizations |
| 9.3.2.Biotechnological companies, |
| 9.3.3.Medical research institutes, |
| 9.3.4.Hospitals |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Source Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Bone Marrow |
| 10.1.2.Umbilical Cord Blood |
| 10.1.3.Peripheral Blood |
| 10.1.4.Lung Tissue |
| 10.1.5.Synovial Tissues |
| 10.1.6.Amniotic Fluids |
| 10.1.7.Adipose Tissues |
| 10.2. Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Injuries |
| 10.2.2.Drug Discovery |
| 10.2.3.Cardiovascular Infraction |
| 10.2.4.Others |
| 10.3. End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Clinical research organizations |
| 10.3.2.Biotechnological companies, |
| 10.3.3.Medical research institutes, |
| 10.3.4.Hospitals |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Source Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Bone Marrow |
| 11.1.2.Umbilical Cord Blood |
| 11.1.3.Peripheral Blood |
| 11.1.4.Lung Tissue |
| 11.1.5.Synovial Tissues |
| 11.1.6.Amniotic Fluids |
| 11.1.7.Adipose Tissues |
| 11.2. Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Injuries |
| 11.2.2.Drug Discovery |
| 11.2.3.Cardiovascular Infraction |
| 11.2.4.Others |
| 11.3. End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Clinical research organizations |
| 11.3.2.Biotechnological companies, |
| 11.3.3.Medical research institutes, |
| 11.3.4.Hospitals |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Source Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Bone Marrow |
| 12.1.2.Umbilical Cord Blood |
| 12.1.3.Peripheral Blood |
| 12.1.4.Lung Tissue |
| 12.1.5.Synovial Tissues |
| 12.1.6.Amniotic Fluids |
| 12.1.7.Adipose Tissues |
| 12.2. Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Injuries |
| 12.2.2.Drug Discovery |
| 12.2.3.Cardiovascular Infraction |
| 12.2.4.Others |
| 12.3. End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Clinical research organizations |
| 12.3.2.Biotechnological companies, |
| 12.3.3.Medical research institutes, |
| 12.3.4.Hospitals |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Source Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Bone Marrow |
| 13.1.2.Umbilical Cord Blood |
| 13.1.3.Peripheral Blood |
| 13.1.4.Lung Tissue |
| 13.1.5.Synovial Tissues |
| 13.1.6.Amniotic Fluids |
| 13.1.7.Adipose Tissues |
| 13.2. Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Injuries |
| 13.2.2.Drug Discovery |
| 13.2.3.Cardiovascular Infraction |
| 13.2.4.Others |
| 13.3. End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Clinical research organizations |
| 13.3.2.Biotechnological companies, |
| 13.3.3.Medical research institutes, |
| 13.3.4.Hospitals |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Cell Applications, Inc |
| 14.2.2.Celprogen, Inc. |
| 14.2.3.Cyagen US Inc. |
| 14.2.4.Genlantis, Inc. |
| 14.2.5.Lonza Group |
| 14.2.6.Mesoblast Limited |
| 14.2.7.MilliporeSigma |
| 14.2.8.Neuromics |
| 14.2.9.Orthofix International N.V. |
| 14.2.10.PromoCell GmbH |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.